Connection
Claudia Amura to Lipopolysaccharides
This is a "connection" page, showing publications Claudia Amura has written about Lipopolysaccharides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.287 |
|
|
|
-
Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J Immunol. 1998 Sep 01; 161(5):2552-60.
Score: 0.123
-
Amura CR, Chen LC, Hirohashi N, Lei MG, Morrison DC. Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. J Immunol. 1997 Nov 15; 159(10):5079-83.
Score: 0.117
-
Amura CR, Silverstein R, Morrison DC. Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun. 1998 Nov; 66(11):5372-8.
Score: 0.031
-
David SA, Silverstein R, Amura CR, Kielian T, Morrison DC. Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother. 1999 Apr; 43(4):912-9.
Score: 0.008
-
Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol. 1998 Apr 15; 160(8):3729-36.
Score: 0.008